How common is Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease, in the United States? For the first time, researchers have a data-backed answer. According to the first-ever data summary from the National ALS Registry, about 4 in every 100,000 people in the U.S. are living with the neurodegenerative disease.
This landmark data comes from the Agency for Toxic Substances and Disease Registry, which launched the national registry to gather comprehensive information on ALS cases across the country. Establishing this baseline prevalence is a critical first step. It provides researchers with a solid foundation to better understand the disease's patterns, identify potential risk factors, and ultimately accelerate the search for effective treatments and a cure.
For patients and families affected by ALS, this registry represents more than just a number—it's a sign of progress and a vital tool for the medical community. At Medicup, we see the immense value of such large-scale data collection. Digital health platforms can play a key role in supporting these efforts, helping to connect patients with specialized care, clinical trials, and support networks, regardless of their location. As registries like this one evolve, telehealth services will be essential for managing care for patients with complex conditions like ALS, ensuring continuous monitoring and access to specialists from the comfort of home.
Source: [CDC Newsroom](https://tools.cdc.gov/api/embed/downloader/download.asp?m=132608&c=308607)